A cytokine-mediated link between innate immunity, inflammation, and cancer

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219

Inflammation and cancer

Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111

Pathogen Recognition and Innate Immunity

Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401

Inflammation and cancer: back to Virchow?

Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746

Interleukin-10 and the Interleukin-10 Receptor

Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528

Smad-dependent and Smad-independent pathways in TGF-β family signalling

Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498

Toll-like receptors and innate immunity

Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099

Interleukin-12 and the regulation of innate resistance and adaptive immunity

Trinchieri, G. (2003) · Nature reviews. Immunology · doi:10.1038/nri1001 · Cited by 4,007

Nuclear factor-κB in cancer development and progression

Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519

Hepatogastroenterology

Chen, L., Li, N., & Ye, H. (2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,208

Inflammatory Bowel Disease

Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183

NF-κB: linking inflammation and immunity to cancer development and progression

Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175

Transforming growth factor-β induces development of the TH17 lineage

Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087

NF-κB in cancer: from innocent bystander to major culprit

Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476

IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer

Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433

NF-κB functions as a tumour promoter in inflammation-associated cancer

Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben‐Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,423

Paradoxical roles of the immune system during cancer development

de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1782 · Cited by 2,299

TGF-β Signaling in Tumor Suppression and Cancer Progression

Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275

Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability

Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769

Radical causes of cancer

Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690

Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation

Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669

Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483

Immune cell migration in inflammation: present and future therapeutic targets

Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313

Cytokine Signaling in 2002

O’Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,137

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Berg, D., Davidson, N. M., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,125

I nterleukin -10 and R elated C ytokines and R eceptors

Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., & Fisher, P. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104622 · Cited by 1,097

IL-23 promotes tumour incidence and growth

Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018

The role of IL-6 and STAT3 in inflammation and cancer

Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 966

Interleukin-17 family and IL-17 receptors

Moseley, T. A., Haudenschild, D. R., Rose, L., & Reddi, A. H. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00002-9 · Cited by 917

IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy

Luo, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 898

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β

Yang, X. Y., Letterio, J. J., Lechleider, R. J., Chen, L., Hayman, R., Gu, H., Roberts, A. B., & Deng, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1280 · Cited by 889

Nod-like proteins in immunity, inflammation and disease

Fritz, J. H., Ferrero, R. L., Philpott, D. J., & Girardin, S. E. (2006) · Nature Immunology · doi:10.1038/ni1412 · Cited by 889

Apo2L/TRAIL and its death and decoy receptors

LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 856

Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis

Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839

Interleukin-17 promotes angiogenesis and tumor growth

Numasaki, M. (2002) · Blood · doi:10.1182/blood-2002-05-1461 · Cited by 831

Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation

Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, É., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 817

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo

Chen, M.-L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., & Khazaie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408197102 · Cited by 806

Inflammation, atrophy, and gastric cancer

Fox, J. G., & Wang, T. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30111 · Cited by 772

CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms

Maloy, K. J., Salaün, L., Cahill, R., Dougan, G., Saunders, N. J. S. G., & Powrie, F. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021345 · Cited by 740

Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.

Parsons, R. E., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 738

TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726

Chronic inflammation and cancer.

Shacter, E. B., & Weitzman, S. A. (2002) · PubMed · Cited by 694

Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer

Rose‐John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 656

The TREM receptor family and signal integration

Klesney‐Tait, J., Turnbull, I. R., & Colonna, M. (2006) · Nature Immunology · doi:10.1038/ni1411 · Cited by 602

Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression

Luo, J., Maeda, S., Hsu, L.-C., Yagita∥, H., & Karin, M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.012 · Cited by 598

The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions

Apte, R. N., Dotan, S., Elkabets, M., White, M. R., Reich, E., Carmi, Y., Song, X., Dvozkin, T., Krelin, Y., & Voronov, E. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9004-4 · Cited by 589

Chronic Inflammation and Cancer

Oshima, M. (2013) · 肥満研究 · Cited by 580

Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4

Watford, W. T., Hissong, B. D., Bream, J. H., Kanno, Y., Muul, L. M., & O’Shea, J. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00211.x · Cited by 578

Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B

Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.3.1104.bloodjournal8731104 · Cited by 563

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

Almasan, A., & Ashkenazi, A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00029-7 · Cited by 547

Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding

Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 526

Myeloid C-type lectins in innate immunity

Robinson, M. J., Sancho, D., Slack, E. M. C., LeibundGut‐Landmann, S., & Sousa, C. R. E. (2006) · Nature Immunology · doi:10.1038/ni1417 · Cited by 525

Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development

Takeda, K., Smyth, M. J., Cretney, E., Hayakawa, Y., Kayagaki, N., Yagita∥, H., & Okumura, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011171 · Cited by 462

Tumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression

Kim, R., Emi, M., Tanabe, K., & Arihiro, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4128 · Cited by 453

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

Lewis, A. M., Varghese, S., Xu, H., & Alexander, H. R. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-48 · Cited by 442

Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 441

Tumor-induced immune dysfunction: the macrophage connection

Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426

IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis

Numasaki, M., Watanabe, M., Suzuki, T., Takahashi, H., Nakamura, A., McAllister, F. M., Hishinuma, T., Goto, J., Lotze, M. T., Kolls, J. K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6177 · Cited by 424

Cytokines in cancer immunity and immunotherapy

Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 417

Interleukin-10 and the immune response against cancer: a counterpoint

D, S. M. M., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 407

Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members

Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364

Interleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism

Benchetrit, F., Cirée, A., Vives, V., Warnier, G., Gey, A., Sautès‐Fridman, C., Fossiez, F., Haicheur, N., Fridman, W. H., & Tartour, É. (2002) · Blood · doi:10.1182/blood.v99.6.2114 · Cited by 347

Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators

Ben‐Baruch, A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 336

TNF-α Inhibits Asbestos-Induced Cytotoxicity via a NF-ΚB-Dependent Pathway, a Possible Mechanism for Asbestos-Induced Oncogenesis

Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604008103 · Cited by 322

Tumor necrosis factor, cancer and anticancer therapy

D, S. M. M., Rossi, C. R., Pilati, P., & Nitti, D. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.11.001 · Cited by 316

Limiting inflammatory responses during activation of innate immunity

Han, J., & Ulevitch, R. J. (2005) · Nature Immunology · doi:10.1038/ni1274 · Cited by 315

STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice

Cho, M., Kang, J. W., Moon, Y., Nam, H.-J., Jhun, J., Heo, S.-B., Jin, H.-T., Min, S., Ju, J., Park, K.-S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5652 · Cited by 314

Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling

Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., et al. (2005) · Nature Medicine · doi:10.1038/nm1282 · Cited by 308

CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice

Erdman, S. E., Poutahidis, T., Tomczak, M. F., Rogers, A. B., Cormier, K. S., Plank, B., Horwitz, B. H., & Fox, J. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63863-1 · Cited by 303

NF‐κB and cancer: Mechanisms and targets

Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 300

Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice

Knight, B., Yeoh, G. C., Husk, K. L., Ly, T., Abraham, L. J., Yu, C., Rhim, J. A., & Fausto, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1809 · Cited by 299

Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

Tartour, É., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E. J., Sastre‐Garau, X., Couturier, J., Mosseri, V., Vives, V., et al. (1999) · PubMed · Cited by 290

Untitled work

(2001) · PubMed · Cited by 279

IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.

Davidson, N. J., Hudak, S. A., Lesley, R., Menon, S., Leach, M. W., & Rennick, D. M. (1998) · PubMed · Cited by 250

Lipopolysaccharide‐induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion

Harmey, J. H., Bucana, C. D., Lu, W., Byrne, A.-M., McDonnell, S., Lynch, C. C., Bouchier-Hayes, D., & Dong, Z. (2002) · International Journal of Cancer · doi:10.1002/ijc.10632 · Cited by 249

Interleukin-17: a mediator of inflammatory responses

Witowski, J., Książek, K., & Jörres, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3228-z · Cited by 246

Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10

Larmonier, N., Marron, M., Zeng, Y., Cantrell, J., Romanoski, A., Sepassi, M., Thompson, S., Chen, X., Andreansky, S. S., & Katsanis, E. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0160-8 · Cited by 229

CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in ApcMin/+ Mice

Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., & Schauer, D. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3104 · Cited by 211

CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.

Erdman, S. E., Rao, V. P., Poutahidis, T., Ihrig, M. M., Ge, Z., Feng, Y., Tomczak, M. F., Rogers, A. B., Horwitz, B. H., & Fox, J. G. (2003) · PubMed · Cited by 210

TGF-β: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

Chen, W., & Wahl, S. M. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00003-0 · Cited by 209

Helicobacter Infection Is Required for Inflammation and Colon Cancer in Smad3-Deficient Mice

Maggio‐Price, L., Treuting, P. M., Zeng, W., Tsang, M., Bielefeldt‐Ohmann, H., & Iritani, B. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2448 · Cited by 209

Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development

Arnott, C. H., Scott, K. A., Moore, R. J., Robinson, S. C., Thompson, R. G., & Balkwill, F. R. (2003) · Oncogene · doi:10.1038/sj.onc.1207317 · Cited by 208

IL-12, But Not IFN-γ, Plays a Major Role in Sustaining the Chronic Phase of Colitis in IL-10-Deficient Mice

Davidson, N. J., Hudak, S. A., Lesley, R., Menon, S., Leach, M. W., & Rennick, D. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3143 · Cited by 208

Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.

Engle, S. J., Ormsby, I., Pawlowski, S. A., Boivin, G. P., Croft, J., Balish, E., & Doetschman, T. C. (2002) · PubMed · Cited by 199

Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis

Kim, S.-J., Im, Y., Markowitz, S. D., & Bang, Y. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00039-8 · Cited by 188

NOD2 and Crohn’s Disease: Loss or Gain of Function?

Eckmann, L., & Karin, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.004 · Cited by 185

The role of tumor stroma in the interaction between tumor and immune system

Blankenstein, T. J. F. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.008 · Cited by 179

Antitumor and Antimetastatic Activity of IL-23

Lo, C.-H., Lee, S., Wu, P.-Y., Pan, W., Su, J. H., Cheng, C., Roffler, S. R., Chiang, B., Lee, C., Wu, C., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.600 · Cited by 171

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors

Jégo, G., Bataille, R., Geffroy-Luseau, A., Descamps, G., & Pellat‐Deceunynck, C. (2006) · Leukemia · doi:10.1038/sj.leu.2404226 · Cited by 163

T cells require TRAIL for optimal graft-versus-tumor activity

Schmaltz, C., Alpdoğan, Ö., Kappel, B. J., Muriglan, S. J., Rotolo, J. A., Ongchin, J., Willis, L. M., Greenberg, A. S., Eng, J. M., Crawford, J. M., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-797 · Cited by 163

Signalling and survival pathways in multiple myeloma

Bommert, K., Bargou, R. C., & Stühmer, T. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.12.026 · Cited by 160

Regulation of Tumor Growth and Metastasis by Interleukin-10: The Melanoma Experience

Huang, S., Ullrich, S. E., & Bar‐Eli, M. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313532 · Cited by 158

IMPLICATION OF TOLL-LIKE RECEPTOR AND TUMOR NECROSIS FACTOR α SIGNALING IN SEPTIC SHOCK

Lin, W.-J., & Yeh, W. (2005) · Shock · doi:10.1097/01.shk.0000180074.69143.77 · Cited by 150

Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt’s Lymphoma

Ogden, C. A., Pound, J. D., Batth, B. K., Owens, S., Johannessen, I., Wood, K., & Gregory, C. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3015 · Cited by 147

The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease

Pidgeon, G. P., Harmey, J. H., Kay, E., Costa, M. D., Redmond, H. P., & Bouchier‐Hayes, D. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6694369 · Cited by 146

Toll-like receptors mediate proliferation and survival of multiple myeloma cells

Bohnhorst, J. Ø., Rasmussen, T., Moen, S. H., Fløttum, M., Knudsen, L. M., Børset, M., Espevik, T., & Sundan, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404225 · Cited by 145

STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells

Hoentjen, F., Sartor, R. B., Ozaki, M., & Jobin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1309 · Cited by 143

Interleukin-10 Inhibits Tumor Metastasis, Downregulates MHC Class I, and Enhances NK Lysis

Kundu, N., & Fulton, A. M. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1176 · Cited by 141

KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways

Osborne, J., Moore, P. S., & Chang, Y. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00083-x · Cited by 137

Immunodeficiency and cancer: prospects for correction

Hadden, J. W. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00060-2 · Cited by 133

IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma

Cozen, W. (2004) · Blood · doi:10.1182/blood-2003-08-2860 · Cited by 129

Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.

Kitakata, H., Nemoto‐Sasaki, Y., Takahashi, Y., Kondo, T., Mai, M., & Mukaida, N. (2002) · PubMed · Cited by 118

Interleukin‐10 in viral diseases and cancer: exiting the labyrinth?

Vicari, A. P., & Trinchieri, G. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00216.x · Cited by 111

The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress

Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1714 · Cited by 103

TGF-beta as a T cell regulator in colitis and colon cancer

Becker, C., Fantini, M. C., & Neurath, M. F. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.004 · Cited by 98

Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership

Dobrovolskaia, M. A., & Kozlov, S. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054629645 · Cited by 96

Ammonium Trichloro(dioxoethylene-o,o′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop

Sredni, B., Weil, M., Khomenok, G. A., Lebenthal, I., Teitz, S., Mardor, Y., Ram, Z., Orenstein, A., Kershenovich, A., Michowiz, S. D., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3179 · Cited by 96

Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer.

Kohno, T., Mizukami, H., Suzuki, M., Saga, Y., Takei, Y., Shimpo, M., Matsushita, T., Okada, T., Hanazono, Y., Kume, A., et al. (2003) · PubMed · Cited by 92

Interleukin‐10 promotes B16‐melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation

García-Hernández, M. D. L. L., Hernández‐Pando, R., Gariglio, P., & Berumen-Campos, J. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01363.x · Cited by 91

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.

Lech‐Marańda, E., Bienvenu, J., Michallet, A., Houot, R., Robak, T., Coiffier, B., & Salles, G. (2006) · PubMed · Cited by 84

Cutting Edge: IL-10-Producing CD4+ T Cells Mediate Tumor Rejection

Segal, B. M., Glass, D. D., & Shevach, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.1 · Cited by 79

Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects

Ugai, S., Shimozato, O., Yu, L., Wang, Y.-Q., Kawamura, K., Yamamoto, H., Yamaguchi, T., Saisho, H., Sakiyama, S., & Tagawa, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700630 · Cited by 73

Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor α

Abroun, S., Ishikawa, H., Tsuyama, N., Liu, S., Li, F., Otsuyama, K., Xu, Z., Obata, M., & Kawano, M. M. (2003) · Blood · doi:10.1182/blood-2003-07-2187 · Cited by 73

The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality

Berger, F. G. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-0726-0 · Cited by 66

Mouse plasmacytoma: an experimental model of human multiple myeloma.

Gadó, K., Silva, S., Pálóczi, K., Domján, G., & Falus, A. (2001) · PubMed · Cited by 61

Interactions of Sequence Variants inInterleukin-1 Receptor–Associated Kinase4and theToll-Like Receptor 6-1-10Gene Cluster Increase Prostate Cancer Risk

Sun, J., Wiklund, F. E., Hsu, F., Bälter, K. A., Zheng, S., Johansson, J., Chang, B., Liu, W., Li, T., Turner, A. R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0645 · Cited by 59

Immune enhancement and anti-tumour activity of IL-23

Hao, J.-S., & Shan, B. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0171-5 · Cited by 55

Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma

Czarneski, J., Lin, Y.-C., Chong, S. Y., McCarthy, B. A., Fernandes, H., Parker, G. A., Mansour, A., Huppi, K. E., Marti, G. E., & Raveche, E. S. (2004) · Leukemia · doi:10.1038/sj.leu.2403244 · Cited by 53

Polymorphism of IL-1 receptor antagonist gene: role in cancer.

Sehouli, J., Mustea, A., Könsgen, D., Katsares, I., & Lichtenegger, W. (2002) · PubMed · Cited by 43

The Role of Interleukin‐1Beta and Other Potential Genetic Markers as Indicators of Gastric Cancer Risk

Troost, E. G. C., Hold, G. L., Smith, M. G., Chow, W., Rbkin, C. S., McColl, K. E. L., & El-Omar, E. M. (2003) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2003/397060 · Cited by 32

Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma before and after hepatic resection.

Taketomi, A., Takenaka, K., Matsumata, T., Shimada, M., Higashi, H., Shirabe, K., Itasaka, H., Adachi, E., Maeda, T., & Sugimachi, K. (1997) · PubMed · Cited by 24

The rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myeloma

Feng, J., Yang, Z., Li, Y., Hu, M., Yu, M., Qin, W., Sun, J. M., & Shen, B. (2006) · Biochimie · doi:10.1016/j.biochi.2006.03.003 · Cited by 7

Immunity, Inflammation, and Cancer

Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755

Oxidative stress, inflammation, and cancer: How are they linked?

Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441

Macrophage Diversity Enhances Tumor Progression and Metastasis

Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,349

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,960

Cytokines – major molecular messengers orchestrate between inflammation and cancer

T.g, S. (2018) · The European Research Journal · doi:10.18621/eurj.347542 · Cited by 2

The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth

Pradhan, R., Kundu, A., & Kundu, C. N. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104311 · Cited by 55

Association of Chronic Inflammation-Associated Cancer With Cytokines

Nakase, H., & Shimomori, Y. (2025) · Cureus · doi:10.7759/cureus.92239 · Cited by 8

The role of pro-inflammatory cytokines in the pathogenesis and progression of neoplasms

Zielińska, K., Kwaśniak, K., Tabarkiewicz, J., & Karczmarek-Borowska, B. (2018) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0012.6931 · Cited by 5

Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer

Tahmasebi, S., Alimohammadi, M., Khorasani, S., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00749-0_25 · Cited by 12